200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 625-52-5
625-52-5 | Ethylurea
CAS No: 625-52-5 Catalog No: AG0034XC MDL No:MFCD00007953
Product Description
Catalog Number:
AG0034XC
Chemical Name:
Ethylurea
CAS Number:
625-52-5
Molecular Formula:
C3H8N2O
Molecular Weight:
88.1084
MDL Number:
MFCD00007953
IUPAC Name:
ethylurea
InChI:
InChI=1S/C3H8N2O/c1-2-5-3(4)6/h2H2,1H3,(H3,4,5,6)
InChI Key:
RYECOJGRJDOGPP-UHFFFAOYSA-N
SMILES:
CCNC(=O)N
UNII:
7K14B03X18
NSC Number:
53556
Properties
Complexity:
52.8
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
88.064g/mol
Formal Charge:
0
Heavy Atom Count:
6
Hydrogen Bond Acceptor Count:
1
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
88.11g/mol
Monoisotopic Mass:
88.064g/mol
Rotatable Bond Count:
1
Topological Polar Surface Area:
55.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.7
Literature
| Title | Journal |
|---|---|
| Toxicity and inflammatory response in Swiss albino mice after intraperitoneal and oral administration of polyurethane nanoparticles. | Toxicology letters 20160330 |
| Diastereocontrolled construction of pactamycin's complex ureido triol functional array. | Organic letters 20120601 |
| Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system. | International journal of nanomedicine 20120101 |
| Denaturation mechanism of BSA by urea derivatives: evidence for hydrogen-bonding mode from fluorescence tools. | Journal of fluorescence 20110701 |
| N-4-iodophenyl-N'-2-chloroethylurea, a novel potential anticancer agent with colon-specific accumulation: radioiodination and comparative in vivo biodistribution profiles. | Investigational new drugs 20100401 |
| PU/PTFE-stimulated monocyte-derived soluble factors induced inflammatory activation in endothelial cells. | Toxicology in vitro : an international journal published in association with BIBRA 20100301 |
| Selective alkylation of beta(II)-tubulin and thioredoxin-1 by structurally related subsets of aryl chloroethylureas leading to either anti-microtubules or redox modulating agents. | Bioorganic & medicinal chemistry 20080801 |
| Characterization and optimization of experimental variables within a reproducible bladder encrustation model and in vitro evaluation of the efficacy of urease inhibitors for the prevention of medical device-related encrustation. | Journal of biomedical materials research. Part B, Applied biomaterials 20060101 |
| Conformational analysis and rotational barriers of alkyl- and phenyl-substituted urea derivatives. | The journal of physical chemistry. A 20050210 |
| Interactions of the neurotoxin vipoxin in solution studied by dynamic light scattering. | Biophysical journal 20040101 |
| Membrane interactions of a new class of anticancer agents derived from arylchloroethylurea: a FTIR spectroscopic study. | Chemistry and physics of lipids 20010601 |
| Inhibition of HIV-1 infection by alkylureas. | AIDS (London, England) 19911201 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.